Maraviroc/cisplatin combination inhibits gastric cancer tumoroid growth and improves mice survival

20253 citationsJournal Articlegold Open Access

Authors

This finding suggests that MVC/CDDP combination could be a potential complementary therapy for GC.

Published in: Biological Research

Volume 58, Issue 1, pp. 4-4

Field-Weighted Citation Impact: 4.32